Published in Int Rev Neurobiol on January 01, 1985
Human retina contains polyamine sensitive [3H]-ifenprodil binding sites: implications for neuroprotection? Br J Ophthalmol (1999) 0.75
AL-8810: a novel prostaglandin F2 alpha analog with selective antagonist effects at the prostaglandin F2 alpha (FP) receptor. J Pharmacol Exp Ther (1999) 1.19
Immortalized human corneal epithelial cells for ocular toxicity and inflammation studies. Invest Ophthalmol Vis Sci (1999) 1.18
The pharmacological properties of the peptide, endothelin. Br J Pharmacol (1989) 1.12
Inhibition of histamine-induced human conjunctival epithelial cell responses by ocular allergy drugs. Arch Ophthalmol (1999) 1.04
Pharmacological characterization of an FP prostaglandin receptor on rat vascular smooth muscle cells (A7r5) coupled to phosphoinositide turnover and intracellular calcium mobilization. J Pharmacol Exp Ther (1998) 0.98
PD117302: a selective agonist for the kappa-opioid receptor. Br J Pharmacol (1988) 0.96
Pharmacological characterization of [(3)H]-prostaglandin E(2) binding to the cloned human EP(4) prostanoid receptor. Br J Pharmacol (2000) 0.96
Functional evidence equating the pharmacologically-defined alpha 1A- and cloned alpha 1C-adrenoceptor: studies in the isolated perfused kidney of rat. Br J Pharmacol (1995) 0.95
Preclinical efficacy of travoprost, a potent and selective FP prostaglandin receptor agonist. J Ocul Pharmacol Ther (2001) 0.93
Prostaglandin DP receptors positively coupled to adenylyl cyclase in embryonic bovine tracheal (EBTr) cells: pharmacological characterization using agonists and antagonists. Br J Pharmacol (1999) 0.93
Rho-Rho kinase pathway in the actomyosin contraction and cell-matrix adhesion in immortalized human trabecular meshwork cells. Mol Vis (2011) 0.92
Topical formulations of novel angiostatic steroids inhibit rabbit corneal neovascularization. Invest Ophthalmol Vis Sci (1997) 0.89
Quantitative autoradiographic visualization and pharmacology of FP-prostaglandin receptors in human eyes using the novel phosphor-imaging technology. J Ocul Pharmacol Ther (1999) 0.89
Comparative effects of topical ocular anti-allergy drugs on human conjunctival mast cells. Ann Allergy Asthma Immunol (1997) 0.87
Dopamine D2-receptors mediate hypothermia in mice: ICV and IP effects of agonists and antagonists. Neurochem Res (1991) 0.87
Endogenous EP4 prostaglandin receptors coupled positively to adenylyl cyclase in Chinese hamster ovary cells: pharmacological characterization. Prostaglandins Leukot Essent Fatty Acids (2000) 0.87
Phospholipid turnover during cell-cycle traverse in synchronous Chinese-hamster ovary cells. Mitogenesis without phosphoinositide breakdown. Biochem J (1988) 0.86
FP prostaglandin receptors mediating inositol phosphates generation and calcium mobilization in Swiss 3T3 cells: a pharmacological study. J Pharmacol Exp Ther (1997) 0.86
Effects of l-glutamate and related amino acids upon the release of [3H]dopamine from rat striatal slices. Brain Res (1978) 0.86
Benzodiazepines compete for thyrotropin-releasing hormone receptor binding: micromolar potency in rat pituitary, retina and amygdala. Neurosci Lett (1983) 0.84
Characterization and autoradiographic localization of TRH receptors in sections of rat brain. Brain Res (1984) 0.84
Problems associated with the binding of L-glutamic acid to synaptic membranes: methodological aspects. J Neurochem (1980) 0.82
Rat brain TRH receptors: kinetics, pharmacology, distribution and ionic effects. Regul Pept (1983) 0.81
Codepletion of serotonin and TRH induces apparent supersensitivity of spinal TRH receptors. Eur J Pharmacol (1983) 0.81
Effects of bradykinin on signal transduction, cell proliferation, and cytokine, prostaglandin E2 and collagenase-1 release from human corneal epithelial cells. Br J Pharmacol (1998) 0.81
Muscarinic M3 receptors mediate total inositol phosphates accumulation in murine HSDM1C1 fibrosarcoma cells. Eur J Pharmacol (1993) 0.80
Sulfhydryl groups in receptor binding of thyrotropin-releasing hormone to rat amygdala. J Neurochem (1984) 0.80
Striatal glutamatergic function: modifications following specific lesions. Brain Res (1982) 0.80
Characteristics of [3H]5-hydroxytryptamine binding to iris-ciliary body tissue of the rabbit. Invest Ophthalmol Vis Sci (1995) 0.80
Prostaglandin-stimulated adenylyl cyclase activity via a pharmacologically defined EP2 receptor in human nonpigmented ciliary epithelial cells. J Ocul Pharmacol Ther (1998) 0.79
Use of a semi-automated, robotic radioimmunoassay to measure cAMP generated by activation of DP-, EP2-, and IP-prostaglandin receptors in human ocular and other cell types. Prostaglandins Leukot Essent Fatty Acids (1998) 0.79
The expression of functionally-coupled B2-bradykinin receptors in human corneal epithelial cells and their pharmacological characterization with agonists and antagonists. Br J Pharmacol (1997) 0.79
The effects of elevated glucose on Na+/K(+)-ATPase of cultured bovine retinal pigment epithelial cells measured by a new nonradioactive rubidium uptake assay. J Ocul Pharmacol Ther (1997) 0.79
Phosphonate analogues of acidic amino acids: inhibition of excitatory amino acid transmitter binding to cerebellar membranes and of the stimulation of cerebellar cyclic GMP levels. Brain Res (1982) 0.78
L-Aspartate binding sites in rat cerebellum: a comparison of the binding of L-[3H]aspartate and L-[3H]glutamate to synaptic membranes. Brain Res (1981) 0.78
Regulation of cerebellar L-[3H]glutamate binding: influence of guanine nucleotides and Na+ ions. Biochem Pharmacol (1981) 0.78
[(3)H]-serotonin release from bovine iris-ciliary body: pharmacology of prejunctional serotonin (5-HT(7)) autoreceptors. Exp Eye Res (2001) 0.77
Neurochemical, pharmacological, and developmental studies on cerebellar receptors for dicarboxylic amino acids. Neurochem Res (1984) 0.77
Micromolar substance P reduces spinal receptor binding for thyrotropin-releasing hormone--possible relevance to neuropeptide coexistence? Neurosci Lett (1983) 0.77
Flow cytometric analysis of internal calcium mobilization via a B2-bradykinin receptor on a subclone of PC-12 cells. J Neurochem (1991) 0.77
Hypoxia-induced [(3)H]D-aspartate release from isolated bovine retina: modulation by calcium-channel blockers and glutamatergic agonists and antagonists. Curr Eye Res (2001) 0.77
A current appreciation of sites for pharmacological intervention in allergic conjunctivitis: effects of new topical ocular drugs. Acta Ophthalmol Scand Suppl (1999) 0.76
Modulation of receptors for thyrotropin-releasing hormone by benzodiazepines: brain regional differences. J Neurochem (1984) 0.76
Biochemical similarity of rat pituitary and CNS TRH receptors. Neurosci Lett (1983) 0.76
Receptors for thyrotropin-releasing hormone (TRH) in rabbit spinal cord. Brain Res (1983) 0.76
Characterization of the m4 muscarinic receptor Ca2+ response in a subclone of PC-12 cells by single cell flow cytometry. Inhibition of the response by bradykinin. J Biol Chem (1991) 0.76
Thyrotropin-releasing hormone gene expression and receptors are differentially modified in limbic foci by seizures. Ann Neurol (1993) 0.76
Bimatoprost, the prodrug of a prostaglandin analogue. Br J Ophthalmol (2008) 0.75
Synthesis and biological activity of a novel 11a-homo (cyclohexyl) prostaglandin. J Med Chem (2000) 0.75
Functional pharmacological evidence for EP2 and EP4 prostanoid receptors in immortalized human trabecular meshwork and non-pigmented ciliary epithelial cells. J Ocul Pharmacol Ther (2001) 0.75
Limbic, hypothalamic, cortical and spinal regions are enriched in receptors for thyrotropin-releasing hormone: evidence from [3H]ultrofilm autoradiography and correlation with central effects of the tripeptide in rat brain. Neurosci Lett (1985) 0.75
AT1 angiotensin receptors mobilize intracellular calcium in a subclone of NG108-15 neuroblastoma cells. J Neurochem (1992) 0.75
A new chromatographic method for measurement of rubidium transport activities in cultured bovine retinal pigment epithelial cells. Ophthalmic Res (1997) 0.75
Binding of L-[3H]glutamate to cerebellar synaptic membranes: stability of receptor sites and effects of protein- and membrane-modifying agents [proceedings]. Biochem Soc Trans (1980) 0.75
1-[2-methoxy-5-(3-phenylpropyl)]-2-aminopropane unexpectedly shows 5-HT(2A) serotonin receptor affinity and antagonist character. J Med Chem (2001) 0.75
Biochemical and autoradiographic studies of TRH receptors in sections of rabbit spinal cord. Biochem Biophys Res Commun (1983) 0.75
Effect of guanine nucleotides on binding of L-3H-glutamate to cerebellar synaptic membranes. Eur J Pharmacol (1980) 0.75
Human, bovine, and rabbit retinal glutamate-induced [3H]D-aspartate release: role in excitotoxicity. Neurochem Res (2000) 0.75
Pharmacology of functional endogenous IP prostanoid receptors in NCB-20 cells: comparison with binding data from human platelets. Prostaglandins Leukot Essent Fatty Acids (2002) 0.75
Radioreceptor binding studies with glutamate and aspartate. Adv Biochem Psychopharmacol (1981) 0.75
Effects of protein- and membrane-modifying agents on the binding of L-[3H]glutamate to cerebellar synaptic membranes. Brain Res (1980) 0.75